Measurement matters: analysis of potential methodological and discrimination biases in assessments of medication treatments for ADHD, and stakeholder views

衡量很重要：分析多动症药物治疗评估中潜在的方法和歧视偏差，以及利益相关者的观点

• 批准号: DI110100034
• 负责人: Dr Anthony Dillon
• 金额: $ 20.53万
• 依托单位: Western Sydney University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Indigenous Researchers Development
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-07-01 至 2014-03-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DI110100034
• 关键词: Measurement; matters; analysis; potential; methodological

This research aims to identify multiple stakeholders' views of the nature of Attention Deficit Hyperactivity Disorder and test if discrimination and survey wording result in bias when assessing the impact of medical treatments. This will result in understandings of discrimination and measurement bias; multiple stakeholders' perceptions; and better methodology in research.

本研究旨在确定多个利益相关者对注意缺陷多动障碍的性质的看法，并测试在评估医学治疗的影响时，歧视和调查措辞是否会导致偏见。这将导致对歧视和衡量偏差的理解;多个利益攸关方的看法;以及更好的研究方法。